Teza Capital Management LLC Gilead Sciences, Inc. Transaction History

Teza Capital Management LLC

$746 Million
Q1 2024

A detailed history of Teza Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 50,637 shares of GILD stock, worth $3.38 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

50,637

Previous 45,922 10.27%

Holding current value

$3.38 Million

Previous $3.72 Million 0.3%

% of portfolio

0.5%

Previous 0.63%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $337,499 - $411,572	4,715 Added 10.27%	50,637 $3.71 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $579,858 - $657,574	7,914 Added 20.82%	45,922 $3.72 Million
Q3 2023 Feb 22, 2024	SELL	$73.94 - $80.67 $684,388 - $746,681	-9,256 Reduced 25.77%	26,658 $2 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.81 Million - $3.07 Million	38,008 New	38,008 $2.85 Million
Q1 2023 Feb 22, 2024	SELL	$77.31 - $88.08 $773,718 - $881,504	-10,008 Reduced 21.79%	35,914 $2.98 Million

Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $4.39 Million - $5 Million	56,819 New	56,819 $4.71 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $565,391 - $645,822	9,496 Added 115.5%	17,718 $1.09 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $2.92 Million - $3.29 Million	-50,534 Reduced 86.01%	8,222 $508,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.22 Million - $1.53 Million	21,035 Added 55.76%	58,756 $3.49 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $1.76 Million - $2 Million	27,176 Added 257.71%	37,721 $2.74 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $713,791 - $770,101	10,545 New	10,545 $737,000
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $3.93 Million - $4.3 Million	-61,968 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $2.56 Million - $2.92 Million	42,674 Added 221.18%	61,968 $4.01 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $85,031 - $96,889	1,501 Added 8.44%	19,294 $1.12 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $1.08 Million - $1.36 Million	-17,376 Reduced 49.41%	17,793 $1.12 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $2.54 Million - $2.95 Million	35,169 New	35,169 $2.71 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $735,088 - $941,542	-11,737 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $1.57 Million - $1.73 Million	-25,524 Reduced 68.5%	11,737 $763,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $2.33 Million - $2.57 Million	37,261 New	37,261 $2.36 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.02 Million - $1.13 Million	-14,338 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $64,555 - $75,301	995 Added 7.46%	14,338 $1.02 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $28,990 - $35,342	398 Added 3.07%	13,343 $1.01 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $921,036 - $1.08 Million	12,945	12,945 $927,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Account

Teza Capital Management LLC Gilead Sciences, Inc. Transaction History